Bio-Techne (TECH) Interest & Investment Income (2009 - 2026)
Bio-Techne (TECH) recorded quarterly Interest & Investment Income of $981000.0 in Q1 2026, up 9.36% quarter-over-quarter from $897000.0 in Q4 2025, and down 4.39% on a YoY basis from $1.0 million in Q1 2025.
Bio-Techne (TECH) Interest & Investment Income (2009 - 2026) Analysis & Trends
Bio-Techne's Interest & Investment Income history runs 18 years deep, the most recent figure standing at $981000.0 for Q1 2026.
- In Q1 2026, Interest & Investment Income fell 4.39% year-over-year to $981000.0; the TTM figure through Mar 2026 stood at $3.4 million (down 18.34% YoY), while the FY2025 annual figure was $3.9 million, up 16.94% from the prior year.
- Interest & Investment Income was $981000.0 for Q1 2026 at Bio-Techne, up from $897000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $1.3 million in Q4 2024 to a low of $168000.0 in Q1 2022.
- Historically, Interest & Investment Income has averaged $813117.6 across 5 years, with a median of $905000.0 in 2024.
- The sharpest annual moves came in 2023 and 2025: Interest & Investment Income jumped 479.76% in 2023, then slumped 35.36% in 2025.
- A 5-year view of Interest & Investment Income shows it stood at $968000.0 in 2022, then fell by 15.7% to $816000.0 in 2023, then soared by 65.2% to $1.3 million in 2024, then sank by 33.46% to $897000.0 in 2025, then advanced by 9.36% to $981000.0 in 2026.
- The last three Interest & Investment Income figures came in at $981000.0 (Q1 2026), $897000.0 (Q4 2025), and $971000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Bio-Techne | 9.04 Bn | 8.83 Bn | 208.29 Mn | 981,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 981,000.00 |
| Dec 31, 2025 | 897,000.00 |
| Sep 30, 2025 | 971,000.00 |
| Jun 30, 2025 | 585,000.00 |
| Mar 31, 2025 | 1.03 Mn |
| Dec 31, 2024 | 1.35 Mn |
| Sep 30, 2024 | 926,000.00 |
| Jun 30, 2024 | 905,000.00 |
| Mar 31, 2024 | 712,000.00 |
| Dec 31, 2023 | 816,000.00 |
| Sep 30, 2023 | 890,000.00 |
| Jun 30, 2023 | 1.04 Mn |
| Mar 31, 2023 | 974,000.00 |
| Dec 31, 2022 | 968,000.00 |
| Sep 30, 2022 | 433,000.00 |
| Jun 30, 2022 | 188,000.00 |
| Mar 31, 2022 | 168,000.00 |
| Dec 31, 2021 | 245,000.00 |
| Sep 30, 2021 | 193,000.00 |
| Jun 30, 2021 | 167,000.00 |